Abstract
Purpose of Review
Formation of the heart requires the coordinated addition of multiple progenitor sources which have undergone different pathways of specification and differentiation. In this review, I aim to put into context how recent studies defining cardiac progenitor heterogeneity build on our understanding of early heart development and also discuss the questions raised by this new insight.
Recent Findings
With the development of sequencing technologies and imaging approaches, it has been possible to define, at high temporal resolution, the molecular profile and anatomical location of cardiac progenitors at the single-cell level, during the formation of the mammalian heart.
Summary
Given the recent progress in our understanding of early heart development and technical advances in high-resolution time-lapse imaging and lineage analysis, we are now in a position of great potential, allowing us to resolve heart formation at previously impossible levels of detail. Understanding how this essential organ forms not only addresses questions of fundamental biological significance but also provides a blueprint for strategies to both treat and model heart disease.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background and Introduction
The heart, blood, and vasculature are the first functional organ system to form during embryogenesis, essential in providing the developing embryo with sufficient oxygen and nutrients [1, 2]. Decisions to commit to a cardiac cell fate are therefore taken early in development, and perturbations to molecular and morphological events of this process frequently result in congenital defects [3].
The first morphologically recognizable heart structure in the developing embryo is the cardiac crescent, which forms at around day 20 of gestation in humans (embryonic day (E) 8.0 in mice, Fig. 1a) [4]. The cardiac crescent is an arc of immature cardiomyocytes in the anterior of the embryo and is where contraction first initiates [5, 6]. Formation of the cardiac crescent requires the coordinated addition of multiple progenitor sources, which have undergone different pathways of specification and differentiation [7, 8]. In vertebrates, this process occurs when stem cells of the epiblast undergo gastrulation, the fundamental process by which the body plan is laid down [9, 10]. During this process, nascent mesoderm forms as pluripotent cells of the epiblast undergo an epithelial to mesenchymal transition and ingress through the primitive streak. This occurs in the caudal region of the embryo at around day 14 in the human (~ E6.25 mouse) [11]. The nascent mesoderm then migrates as two bilateral sheets (mesodermal wings) toward the anterior of the embryo (Fig. 1b, c). In this anterior region, the mesodermal wings meet at the midline and buckle to form the cardiac crescent [12]. During this migration, the nascent mesoderm specifies to form cardiac progenitors before differentiating into cell types such as immature cardiomyocytes. The cardiac crescent subsequently fuses at the midline to create the linear heart tube, before undergoing a complex process of morphogenetic remodeling to form the 4-chambered heart [13]. During these later stages of development, a heterogeneous population of progenitors continue to add to the heart, differentiating into a diverse range of cell types and enabling the heart to grow and maintain its vital function [14,15,16].
Understanding heart formation aids our knowledge of congenital heart disease, allowing us to establish the underlying causes of defects. Such understanding provides a blueprint to generate biology relevant in vitro models as well as insight into regenerative approaches to treat heart diseases, such as the damage caused during a heart attack. Congenital heart defects are the most common type of birth defect, being diagnosed in at least 1 in 125 births: equating to around 98 babies each day in the European Union [17]. In humans, the developing heart is most vulnerable to defects between 3 and 7 weeks, coinciding with when heart formation first begins and when the largest morphological rearrangements occur [18, 19]. Heart attacks, the manifestation of coronary artery disease, are the leading cause of death worldwide, accounting for 1.8 million deaths each year in Europe alone [20, 21]. The development of regenerative approaches to treat this disease by the restoration of function is vital.
Recently, single-cell-based approaches have revealed an unappreciated complexity in regards to cardiac progenitor heterogeneity, providing new and exciting opportunities to learn how the heart forms during early embryonic development [22••, 23••, 24,25,26,27,28]. This review will examine how our recent transcriptional and anatomical characterization of cardiac progenitors relates to previously defined heart fields and myocyte lineages as well as explore the questions this characterization raises.
Heart Fields
During formation of the heart, cardiac progenitors reside in bilateral regions of the embryo, termed heart fields (Fig. 1b). These heart-forming fields are anatomically defined based on the expression patterns of molecular markers (Table 1). Classically, cardiac progenitors have been attributed to two main heart fields, termed the first and second heart fields (FHF and SHF, Fig. 1b) [29]. The FHF represents cardiac progenitors which rapidly differentiate to give rise to the cardiomyocytes of the cardiac crescent and lose proliferative capacity. The SHF is a wider domain of progenitors, dorsal and medial to the cardiac crescent, which maintain their proliferative capacity and continue to add cells to the cardiac crescent as it develops [30]. As a result of advances in sequencing technologies and multiplexed imaging approaches, it has been possible to define, at high temporal resolution, the molecular profile of cardiac progenitors at the single-cell level, as well as anatomically map these transcriptionally distinct progenitor states during heart formation in the intact embryo [22••, 23••]. This has enabled a significant advance in our understanding of cardiac progenitors and thus our ability to define heart fields, taking into account a combination of genes rather than single markers.
Characterization of a distinct FHF progenitor has remained elusive given its rapid differentiation into cardiomyocytes at the onset of cardiac crescent formation. Thus, there are limited FHF markers due to the difficulty in distinguishing unique genes, which aren’t broad markers of cardiomyocyte differentiation (e.g., Actn2, Tnnt2) (Table 1). This highlights the difficulty in precisely defining heart fields using markers and means specific contours vary between authors. Defining hearts fields based on marker expression means that the cell populations identified will vary depending on the gene used and the stage of development assessed. Alternatively, defining heart fields based on anatomical location means that heart fields vary depending on the morphological landmark used and the stage of embryonic development (e.g., position within the mesodermal wing or location relative to the cardiac crescent). It also means that classic heart field marker genes overlap with different heart fields (e.g., Tbx5, Table 1) [31, 32]. By anatomically characterizing, at high temporal and spatial resolution, progenitor populations based on their entire transcriptome at the single-cell level provide increased clarity when defining heart fields.
Historically, the early cardiomyocytes of the cardiac crescent were termed the FHF; however, given these cells have differentiated into immature cardiomyocytes, they do not truly represent a cardiac progenitor population. In contrast, we recently observed that a FHF-like progenitor state is maintained from emergence of the cardiac crescent to formation of linear heart tube [22••]. Anatomically, this FHF-like state was located at the boundary between more progenitor-like states and differentiating cardiomyocytes (Fig. 1f). This may suggest that FHF progenitors are maintained during cardiac crescent development or that a FHF-like profile represents a transitory molecular state during differentiation toward cardiomyocytes.
SHF cardiac progenitors were initially defined because of their later addition to the heart tube and have been more straightforward to characterize, thanks to their maintained proliferative presence and distinct anatomical location [33,34,35]. The SHF has been defined based on the expression of genes such as Fgf10, Isl1, and Tbx1 and can be subdivided into two anatomically distinct populations termed the posterior SHF (pSHF = Tbx1 positive; Tbx5 positive) and anterior SHF (aSHF = Tbx1 positive; Tbx5 negative) (Table 1) [36, 37]. Based on marker gene expression, aSHF and pSHF progenitors have been detected during early mesoderm formation. When using molecular markers to define heart fields during early development caution is required due to the dynamic and transient nature of gene expression during gastrulation and early organogenesis. For example, the SHF marker, Islet1, is broadly expressed in all cardiac progenitors prior to formation of the cardiac crescent but is rapidly downregulated upon cardiomyocyte differentiation over a period of < 6 h (Table 1) [22••, 38, 39]. Thus, it is fundamental to characterize the expression of molecular markers in high temporal resolution during in vivo development, especially when assessing lineage potential using specific marker genes and inducible Cre lines.
Recently, a novel anatomically distinct population of cardiac progenitors located in a region distinct from the traditional FHF and SHFs has been discovered [22••, 23••]. Initially, this population of progenitors resides in a region adjacent to the forming cardiac crescent, at the confluence between the splanchnic and extraembryonic mesoderm (Fig. 1e, f). As the heart begins to form and rostral folding occurs, this population becomes positioned in an arc overlying the cardiac crescent and sandwiched against the endoderm, before extending caudally to also occupy a region at the inflow of the heart (Fig. 1f). As well as being anatomically distinct, this population has a unique transcriptional signature in comparison to previously reported cardiac progenitor populations. It strongly expresses a distinct combination of FHF and SHF markers (e.g., Tbx5 [31], Hand1 [40], Hoxb1 [41]) but lowly expresses the archetypal cardiac progenitor marker Nkx2-5 [42] (Table 1). It also expresses more specific markers like Mab21l2 and Hoxd1. Based on the expression of Mab21l2, we termed this region the Juxta Cardiac Field (JCF). A subsequent study by a separate group revealed a broader region of similar progenitors, earlier in development and which extended further into the extraembryonic mesoderm, as defined by Hand1 (Fig. 1e) [23••].
The JCF has a maintained proliferative status throughout cardiac crescent development, making it distinct from the typical FHF and suggesting it could represent a maintained progenitor pool like the SHF [22••]. It also expresses a specific set of genes encoding signaling molecules involved in cardiomyocyte differentiation such as Bmp4 and Wnt2. Given the JCF’s dynamic anatomical location as well as its expression of signaling molecules, it is likely to alter local signaling environments, for example, signals from the endoderm, which can influence midline fusion of the mesodermal wings and thus potentially regulate cell fate decisions [43, 44].
Using single-cell computational approaches, it is possible to infer differentiation trajectories and investigate the molecular changes that occur during the transition from cardiac progenitor to myocyte. However, any conclusions drawn from these observations must be validated in vivo. Computational analysis of our recent single-cell RNAseq data identified two trajectories by which cardiac progenitors could generate cardiomyocytes during a developmental period spanning cardiac crescent development (Fig. 1g) [22••]. These trajectories occupied specific anatomical locations within the anterior cardiac crescent forming region of the embryo. One trajectory showed a distinct transition from SHF progenitors toward cardiomyocytes and was located in a medial and dorsal position relative to the cardiac crescent. The second was more complicated and represented the molecular convergence of both JCF and SHF progenitors, through a FHF-like state prior to cardiomyocyte differentiation. This trajectory was positioned ventral to the cardiac crescent. Lineage analysis of Mab21l2 expressing progenitors confirmed the computational prediction that the JCF could give rise to cardiomyocytes, although we do not know what proportion of the heart this population contributes. This analysis also revealed that the JCF could contribute to the epicardium; however, we do not know whether the JCF progenitors are multipotent [23••]. Lineage analysis of the earlier Hand1 embryonic/extraembryonic spanning domain supported this finding and showed that these earlier progenitors are multipotent. However, we did not examine early enough stages to conclude whether this FHF-like transition state was expressed prior to cardiac crescent emergence, and thus cannot conclude whether a FHF progenitor population exists that is molecularly distinct from the FHF-like transition state. Our computational analysis also suggests that SHF progenitors can give rise to cardiomyocytes via two distinct transitory cell states (FHF-like and SHF-like). This may represent a separation between the aSHF and pSHF, with the pSHF and JCF transitioning through a FHF-like state. Alternatively, it could suggest the presence of a cardiac progenitor, which can transition through different intermediate states dependent on its anatomical location, although these interpretations require further in vivo lineage exploration.
Cardiomyocyte Lineage
Lineage represents the developmental history of a differentiated cell in the wild-type setting. Typically, this is examined by labeling populations of cells which express a given marker gene at a specific timepoint, but it is more informative when examining individually labeled cells (clonal analysis). While equated conceptually, cardiac lineages (as described by clonal analyses) and cardiac fields (molecularly defined anatomical patterns) are distinct. In the intact murine embryo, myocardial lineages were first delineated using an nlaacZ reporter gene in the α-cardiac actin locus, enabling retrospective clonal analysis [45]. Spontaneous but rare labeling events by intergenic recombination into a functional lacZ gene allow any progenitor to be uncovered, but it is retrospective. This revealed the presence of two distinct cardiac lineages termed the first and second lineage (not to be confused with the FHF and SHF) (Fig. 1h). In the looping heart at E8.5, the first lineage colonized both left and right ventricles, atrioventricular canal, and venous pole, while the second lineage contributed to the right ventricle, atrioventricular canal, venous pole, and the outflow tract. The only regions of the heart that were entirely derived from a single lineage were the left ventricle (first lineage) and outflow tract (second lineage). Rare small clones colonizing both the right and left ventricles were also identified, indicating the existence of a common cardiac progenitor, although the temporal dynamics of such a progenitor cannot be determined using this approach.
With the development of fluorescent-based clonal reporters such as confetti or mosaic analysis with double markers (MADM), a more targeted approach has been taken to assess cardiac lineages by labeling Mesp1-positive cardiac progenitors [46, 47]. Mesp1 is transiently expressed in the forming mesoderm during gastrulation [48]. Using an inducible system, analysis of Mesp1-derived progenitors at E12.5 supported the presence of two distinct lineages but showed a greater degree of anatomical distinction compared to the earlier retrospective studies (Fig. 1h) [46]. Early mesoderm labeling resulted in clones only being detected in the left ventricle, while later mesoderm labeling resulted in clones solely in the right ventricle, atria, and outflow tract. A similar study using Mesp1-Cre and MADM showed that Mesp1-positive cardiac progenitors gave rise to distinct regions of the heart, again with no clones spanning the left and right ventricles [47]. These findings are in contrast to the earlier retrospective clonal analysis and suggest that cardiac lineage is predefined in the streak or later. This discrepancy could be related to the labeling approach used and the observation that while Mesp1-Cre labels the majority of the cardiac crescent, there is a population of progenitors that are not labeled. Mesp1-Cre has been shown to label around 70% of cardiomyocytes [49]. During heart formation, non-labeled cells are located in the medial region of the cardiac crescent (Fig. 1i). This non-labeling may reflect the transient nature of Mesp1 expression in early progenitors (e.g., insufficient time for recombination) and the technical caveats of the labeling approaches used (e.g., temporal delay in recombination following administration to mother, uncertainty regarding the true stage of embryo labeled) or a Mesp1-independent differentiation pathway. The other difference between the Mesp1-Cre- and nlaacZ-based approaches is the stage of heart development examined. The nlaacZ approach predominantly examined looping hearts at E8.5, while the Mesp1 studies focused on later stages once looping was complete (E10.5/E12.5) and did not image the entire heart, now possible with tissue clearing approaches such as CUBIC or Ce3D [50, 51]. Interestingly, using the inducible Mesp1 approach clones could be detected spanning both the presumptive left and right ventricle at E8.5, raising the question as to how cardiac lineage is resolved over subsequent development.
In summary, both the nlaacZ and Mesp1 clonal analysis and our computational lineage inference support the concept of two cardiomyocyte lineages; however, understanding their temporal dynamics, contribution to specific cardiac chambers, and relation to defined cardiac progenitor populations needs to be further resolved. For example, do the recently identified JCF and broader Hand1 domain represent cells of the first lineage?
When Is Cardiomyocyte Progenitor Fate Assigned?
To understand the fundamentals of heart formation and gain potential therapeutic insight, it is important to define when and how cardiac progenitors commit to specific cell fates (i.e., when can a cell’s fate not be reversed or transformed). During gastrulation, cardiac progenitors arise from the primitive streak at different times and in distinct anatomical locations [52,53,54,55,56,57]. For example, the earliest progenitors will emerge from a region of the primitive streak at the embryonic/extraembryonic boundary(~ E6.5). At slightly later stages of development (~ E7.0), the primitive streak elongates and cells will also ingress in a more rostral region. Given the difficulty in delineating the temporal and spatial aspects of gastrulation and the dynamic expression of genes during this short window of development, it is hard to define whether early cardiac progenitors represent predefined populations within the primitive streak or whether heart field and cardiac chamber fate is more plastic and regulated by the specific signaling environments nascent mesoderm experiences during migration. In support of an early segregation, small populations of Mesp1-derived cardiac progenitors expressing markers of the FHF, aSHF, and pSHF are prepatterned during early gastrulation [27]. They are thus suggested to commit to different fates and heart regions, although the clonal fate of these populations has not been directly assessed. The early specification of cardiac progenitors to distinct chamber fates has been suggested to occur within the primitive streak [58]; however, this did not assess clonal dynamics and is subject to the caveats of using recombinase-based approaches. In a human gastrulating embryo at a comparable stage of development, it was difficult to identify distinct cardiac progenitor populations, but this may represent species differences or the single embryo analyzed [59].
Contrary to the notion that cardiac progenitors represent predefined states in the primitive streak, it has been suggested that cardiac progenitor fate is governed by positional cues and the anatomical location at which they arise and add to the heart [60]. The anatomical mapping of cardiac progenitors post mesoderm migration shows that transitory differentiation states are located at the boundaries of the cardiac crescent (Fig. 1f). This highlights how morphology and cardiac cell fate decisions are inextricably linked. In support of the positional cue argument, it has been shown that early cardiac progenitors do have some plasticity and that the translocation of cardiac progenitors to different anatomical domains during early development can alter their fate [61,62,63]. Recent live imaging approaches have shown that during mesoderm migration, there is a considerable amount of cell-mixing [64]. The rearrangement and crossing of cell tracks highlight the potential for early cardiac progenitors to have considerable early plasticity with respect to their final cell fate. Together with the distinct location of progenitor transition states, this could suggest that patterning occurs post migration and that it is the position of cardiac progenitors within the mesodermal wings, as cardiac crescent formation and rostral folding begin that influences commitment to a certain cell fate.
In summary, while mesoderm subtypes (e.g., extraembryonic and lateral plate) arise in a spatiotemporal manner, the dynamics of mesoderm migration and the distinct location of progenitor transition states support the idea that cardiac progenitor fate isn’t rigid during early gastrulation. Understanding progenitor plasticity is of interest when examining disease and how progenitor fate is impacted when early developmental processes and gene networks are dysregulated [65]. For example, disrupting mesodermal wing migration and midline fusion results in a phenotype termed cardia bifida. This defect is characterized by the formation of two heart tubes, which independently beat and look grossly normal [66,67,68]; however, there is dysregulation in right and left ventricular markers [69].
Conclusion/Outlook
Thanks to the development of single-cell resolution approaches, there has been a significant increase in our understanding and characterization of cardiac progenitors. The field is therefore in an exciting position to explore the questions raised by these recent advances. Addressing these questions will be facilitated by technological developments such as those related to high-resolution time-lapse imaging and clonal lineage analysis. With the use of light-sheet microscopy, it is now possible to image periods of mouse embryonic development spanning the onset of gastrulation to LHT formation [64, 70]. Coupling this with the ability to track single cells, as well as remove motion artifacts due to contraction, means that cardiac cell fate decisions can now be visualized during formation of the heart and thus lineages can be directly assessed. Clonal analysis techniques have also been developed which enable a more global view of lineage dynamics such as CRISPR-based genetic scars and DNA barcodes, as well as approaches which don’t require genetic manipulations, using somatic mutations or variations in mitochondrial DNA to reconstruct cell lineage [71,72,73,74,75,76]. Combining these approaches with perturbations will provide unprecedented insight into how the heart forms and identify the mechanisms and pathways regulating cardiac progenitor specification and differentiation. This insight will not only address questions of fundamental biological significance but will provide insight into the causes of congenital heart defects, a blueprint to generate biologically relevant in vitro models and aid in the development of cell-based regenerative strategies to treat disease.
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Christoffels V, Jensen B. Cardiac Morphogenesis: Specification of the Four-Chambered Heart. Cold Spring Harb Perspect Biol. 2020;12:1–18. https://doi.org/10.1101/CSHPERSPECT.A037143.
Tyser RCV, Srinivas S. The First Heartbeat—Origin of Cardiac Contractile Activity. Cold Spring Harb Perspect Biol. 2019. https://doi.org/10.1101/cshperspect.a037135.
Morton SU, Quiat D, Seidman JG, Seidman CE. Genomic frontiers in congenital heart disease. Nat Rev Cardiol. 2021;19(1):26–42. https://doi.org/10.1038/s41569-021-00587-4.
O’Rahilly R, Müller F. Developmental stages in human embryos. Contrib. Embryol., Carnegie Inst Wash. 1987;637.
Tyser RCV, Miranda AMA, Chen CM, Davidson SM, Srinivas S, Riley PR. Calcium handling precedes cardiac differentiation to initiate the first heartbeat. Elife. 2016;5.
Männer J. When Does the Human Embryonic Heart Start Beating? A Review of Contemporary and Historical Sources of Knowledge about the Onset of Blood Circulation in Man. J Cardiovasc Dev Dis. 2022;9.
Meilhac SM, Buckingham ME. The deployment of cell lineages that form the mammalian heart. Nat Rev Cardiol. 2018;15:705–24. https://doi.org/10.1038/s41569-018-0086-9.
Swedlund B, Lescroart F. Cardiopharyngeal Progenitor Specification: Multiple Roads to the Heart and Head Muscles. Cold Spring Harb Perspect Biol. 2020;12:a036731. https://doi.org/10.1101/CSHPERSPECT.A036731.
Stern CD. Gastrulation: from cells to embryo. 2004.
Bardot ES, Hadjantonakis AK. Mouse gastrulation: Coordination of tissue patterning, specification and diversification of cell fate. Mech Dev. 2020. https://doi.org/10.1016/j.mod.2020.103617.
Tyser RCV, Srinivas S. Recent advances in understanding cell types during human gastrulation. Semin Cell Dev Biol. 2022;131:35–43. https://doi.org/10.1016/J.SEMCDB.2022.05.004.
Ivanovitch K, Temiño S, Torres M. Live imaging of heart tube development in mouse reveals alternating phases of cardiac differentiation and morphogenesis. Elife. 2017. https://doi.org/10.7554/elife.30668.
Le Garrec JF, Domínguez JN, Desgrange A, Ivanovitch KD, Raphaël E, Bangham JA, et al. A predictive model of asymmetric morphogenesis from 3D reconstructions of mouse heart looping dynamics. Elife. 2017. https://doi.org/10.7554/ELIFE.28951.
Lie-Venema H, Van Den Akker N, Bax NAM, Winter EM, Maas S, Kekarainen T, et al. Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. Sci World J. 2007;7:1777–98. https://doi.org/10.1100/TSW.2007.294.
Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the mammalian cardiac neural crest. Development. 2000;127:1607–16. https://doi.org/10.1242/DEV.127.8.1607.
Nakano A, Nakano H, Smith KA, Palpant NJ. The developmental origins and lineage contributions of endocardial endothelium. Biochim Biophys Acta. 2016;1863:1937–47. https://doi.org/10.1016/J.BBAMCR.2016.01.022.
Dolk H, Loane M, Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123:841–9. https://doi.org/10.1161/CIRCULATIONAHA.110.958405.
Hikspoors JPJM, Kruepunga N, Mommen GMC, Köhler SE, Anderson RH, Lamers WH. A pictorial account of the human embryonic heart between 3.5 and 8 weeks of development. Commun Biol. 2022;5.
Bakker BSD, Jong KHD, Hagoort J, Bree KD, Besselink CT, Kanter FECD, et al. An interactive three-dimensional digital atlas and quantitative database of human development. Science. 2016. https://doi.org/10.1126/science.aag0053.
Guha K, McDonagh T. Heart failure epidemiology: European perspective. Curr Cardiol Rev. 2013;9:123–7. https://doi.org/10.2174/1573403X11309020005.
Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J. 2013;34:3028–34. https://doi.org/10.1093/EURHEARTJ/EHT356.
•• Tyser RCV, Ibarra-Soria X, McDole K, Jayaram SA, Godwin J, Van Den Brand TAH, et al. Characterization of a common progenitor pool of the epicardium and myocardium. Science. 2021;371. Findings from this study describe both the anatomical and transcriptional profile of cardiac progenitors during heart formation, identifying a cardiac progenitor population with distinct characteristics, in contrast to typically cardiac progenitor populations.
•• Zhang Q, Carlin D, Zhu F, Cattaneo P, Ideker T, Evans SM, et al. Unveiling Complexity and Multipotentiality of Early Heart Fields. Circ Res. 2021;129:474–87. https://doi.org/10.1161/CIRCRESAHA.121.318943. Findings from this study reveal a multipotent cardiac progenitor population which is located in an anatomical region outside of the typical heart fields and can give rise to multiple different cells of the heart.
Sendra M, Domínguez J, Torres M, Ocaña O. Dissecting the complexity of early heart progenitor cells. J Cardiovasc Dev Dis. 2021;9:5. https://doi.org/10.3390/jcdd9010005.
Xiong H, Luo Y, Yue Y, Zhang J, Ai S, Li X, et al. Single-cell transcriptomics reveals chemotaxis-mediated intraorgan crosstalk during cardiogenesis. Circ Res. 2019. https://doi.org/10.1161/CIRCRESAHA.119.315243.
de Soysa TY, Ranade S, Okawa S, Ravichandran S, Huang Y, Salunga H, et al. Single-cell analysis of cardiogenesis reveals basis for organ-level developmental anomalies. Nature. 2019. https://doi.org/10.1038/s41586-019-1414-xID.
Lescroart F, Wang X, Lin X, Swedlund B, Gargouri S, Sànchez-Dànes A, et al. Defining the earliest step of cardiovascular lineage segregation by single-cell RNA-seq. Science. 2018. https://doi.org/10.1126/science.aao4174.
Li G, Xu A, Sim S, Priest JR, Tian X, Khan T, et al. Transcriptomic profiling maps anatomically patterned subpopulations among single embryonic cardiac cells. Dev Cell. 2016. https://doi.org/10.1016/j.devcel.2016.10.014.
Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet. 2005;6:826–35. https://doi.org/10.1038/NRG1710.
Kelly RG, Buckingham ME, Moorman AF. Heart fields and cardiac morphogenesis. Cold Spring Harb Perspect Med. 2014;4:a015750. https://doi.org/10.1101/CSHPERSPECT.A015750.
Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG, et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt- Oram syndrome. Dev Biol. 1999;211:100–8. https://doi.org/10.1006/dbio.1999.9298.
Xie L, Hoffmann AD, Burnicka-Turek O, Friedland-Little JM, Zhang K, Moskowitz IP. Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation. Dev Cell. 2012;23:280. https://doi.org/10.1016/J.DEVCEL.2012.06.006.
Waldo KL, Kumiski DH, Wallis KT, Stadt HA, Hutson MR, Platt DH, et al. Conotruncal myocardium arises from a secondary heart field. Development. 2001;128:3179–88. https://doi.org/10.1242/DEV.128.16.3179.
Kelly RG, Brown NA, Buckingham ME. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell. 2001;1:435–40.
Mjaatvedt CH, Nakaoka T, Moreno-Rodriguez R, Norris RA, Kern MJ, Eisenberg CA, et al. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol. 2001;238:97–109. https://doi.org/10.1006/DBIO.2001.0409.
Rana MS, Théveniau-Ruissy M, De Bono C, Mesbah K, Francou A, Rammah M, et al. Tbx1 coordinates addition of posterior second heart field progenitor cells to the arterial and venous poles of the heart. Circ Res. 2014;115:790–9. https://doi.org/10.1161/CIRCRESAHA.115.305020.
Bertrand N, Roux M, Ryckebüsch L, Niederreither K, Dollé P, Moon A, et al. Hox genes define distinct progenitor sub-domains within the second heart field. Dev Biol. 2011;353:266–74. https://doi.org/10.1016/J.YDBIO.2011.02.029.
Prall OWJ, Menon MK, Solloway MJ, Watanabe Y, Phane Zaffran S, Bajolle F, et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell. 2007;128:947–59. https://doi.org/10.1016/j.cell.2007.01.042.
Ma Q, Zhou B, Pu WT. Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev Biol. 2008;323:98–104. https://doi.org/10.1016/J.YDBIO.2008.08.013.
Firulli AB, McFadden DG, Lin Q, Srivastava D, Olson EN. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1. Nat Genet. 1998. https://doi.org/10.1038/ng0398-266.
Stefanovic S, Laforest B, Desvignes JP, Lescroart F, Argiro L, Maurel-Zaffran C, et al. Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation. Elife. 2020;9:1–32.
Harvey RP. NK-2 homeobox genes and heart development. Dev Biol. 1996. https://doi.org/10.1006/dbio.1996.0212.
Paige SL, Plonowska K, Xu A, Wu SM. Molecular regulation of cardiomyocyte differentiation. Circ Res. 2015;116:341–53.
Bloomekatz J, Singh R, Prall OWJ, Dunn AC, Vaughan M, Loo CS, et al. Platelet-derived growth factor (PDGF) signaling directs cardiomyocyte movement toward the midline during heart tube assembly. Elife. 2017. https://doi.org/10.7554/ELIFE.21172.
Meilhac SM, Esner M, Kelly RG, Nicolas JF, Buckingham ME. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell. 2004. https://doi.org/10.1016/S1534-5807(04)00133-9.
Lescroart F, Chabab S, Lin X, Rulands S, Paulissen C, Rodolosse A, et al. Early lineage restriction in temporally distinct populations of Mesp1 progenitors during mammalian heart development. Nat Cell Biol. 2014;16:829–40. https://doi.org/10.1038/NCB3024.
Devine WP, Wythe JD, George M, Koshiba-Takeuchi K, Bruneau BG. Early patterning and specification of cardiac progenitors in gastrulating mesoderm. Elife. 2014; 1–23.
Saga Y, Hata N, Kobayashi S, Magnuson T, Seldin MF, Taketo MM. MesP1: a novel basic helix-loop-helix protein expressed in the nascent mesodermal cells during mouse gastrulation. Development. 1996.
Ragni CV, Diguet N, Le Garrec JF, Novotova M, Resende TP, Pop S, et al. Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth. Nat Commun. 2017;8:1–11.
Li W, Germain RN, Gerner MY. High-dimensional cell-level analysis of tissues with Ce3D multiplex volume imaging. Nat Protoc. 2019;14:1708–33.
Susaki EA, Tainaka K, Perrin D, Kishino F, Tawara T, Watanabe TM, et al. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell. 2014;157:726–39. https://doi.org/10.1016/j.cell.2014.03.042.
Parameswaran M, Tam PPL. Regionalisation of cell fate and morphogenetic movement of the mesoderm during mouse gastrulation. Dev Genet. 1995;17:16–28.
Tam PPL, Beddington RSP. The formation of mesodermal tissues in the mouse embryo during gastrulation and early organogenesis. Development. 1987;99:109–26.
Stalsberg H, DeHaan RL. The precardiac areas and formation of the tubular heart in the chick embryo. Dev Biol. 1969;19:128–59. https://doi.org/10.1016/0012-1606(69)90052-9.
Lawson KA, Meneses JJ, Pedersen RA. Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development. 1991;113:891–911.
Garcia-Martinez V, Schoenwolf GC. Primitive-streak origin of the cardiovascular system in avian embryos. Dev Biol. 1993;159:706–19.
Redkar A, Montgomery M, Litvin J. Fate map of early avian cardiac progenitor cells. Development. 2001;128:2269–79.
Ivanovitch K, Soro-Barrio P, Chakravarty P, Jones RA, Bell DM, Gharavy SNM, et al. Ventricular, atrial, and outflow tract heart progenitors arise from spatially and molecularly distinct regions of the primitive streak. PLoS Biol. 2021;19:e3001200.
Tyser RC, Mahammadov E, Nakanoh S, Vallier L, Scialdone A, Srinivas S. Single-cell transcriptomic characterization of a gastrulating human embryo. Nature. 2021;600:285–9.
Moorman AFM, Christoffels VM, Anderson RH, van den Hoff MJB. The heart-forming fields: one or multiple? Philos Trans R Soc B Biol Sci. 2007;362:1257–65.
Satin J, Fujii S, DeHaan RL. Development of cardiac beat rate in early chick embryos is regulated by regional cues. Dev Biol. 1988;129:103–13. https://doi.org/10.1016/0012-1606(88)90165-0.
Lopez-Sanchez C, Garcia-Masa N, Gañan CM, Garcia-Martinez V. Movement and commitment of primitive streak precardiac cells during cardiogenesis. Int J Dev Biol. 2009;53:1445–55.
Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien C, Schultheiss TM, et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006;127:1137–50.
Dominguez MH, Krup AL, Muncie JM, Bruneau BG. Graded mesoderm assembly governs cell fate and morphogenesis of the early mammalian heart. Cell. 2023;186:479-496.e23.
Gonzalez-Teran B, Pittman M, Felix F, Thomas R, Richmond-Buccola D, Hüttenhain R, et al. Transcription factor protein interactomes reveal genetic determinants in heart disease. Cell. 2022;185:794-814.e30. https://doi.org/10.1016/J.CELL.2022.01.021.
DeHaan RL. Cardia bifida and the development of pacemaker function in the early chick heart. Dev Biol. 1959;1:586–602. https://doi.org/10.1016/0012-1606(59)90019-3.
Chen JN, Haffter P, Odenthal J, Vogelsang E, Brand M, Van Eeden FJM, et al. Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development. 1996;123:293–302.
Stainier DYR, Fouquet B, Chen JN, Warren KS, Weinstein BM, Meiler SE, et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 1996;123:285–92.
Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, Collen D, et al. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1a. Cardiovasc Res. 2003;60:569–79.
McDole K, Guignard L, Amat F, Berger A, Malandain G, Royer LA, et al. In toto imaging and reconstruction of post-implantation mouse development at the single-cell level. Cell. 2018;175:859–76. https://doi.org/10.1016/j.cell.2018.09.031.
Spanjaard B, Hu B, Mitic N, Olivares-Chauvet P, Janjuha S, Ninov N, et al. Simultaneous lineage tracing and cell-type identification using CRISPR–Cas9-induced genetic scars. Nat Biotechnol. 2018;36(5):469–73.
Alemany A, Florescu M, Baron CS, Peterson-Maduro J, Oudenaarden AV. Whole-organism clone tracing using single-cell sequencing. Nature. 2018;556:108–12.
Chow KHK, Budde MW, Granados AA, Cabrera M, Yoon S, Cho S, et al. Imaging cell lineage with a synthetic digital recording system. Science. 2021;372.
Park S, Mali NM, Kim R, Choi JW, Lee J, Lim J, et al. Clonal dynamics in early human embryogenesis inferred from somatic mutation. Nature. 2021;597:393–7.
Coorens THH, Moore L, Robinson PS, Sanghvi R, Christopher J, Hewinson J, et al. Extensive phylogenies of human development inferred from somatic mutations. Nature. 2021;597:387–92.
Miller TE, Lareau CA, Verga JA, DePasquale EAK, Liu V, Ssozi D, et al. Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations. Nat Biotechnol. 2022;40:1030–4.
Acknowledgements
R.T. is funded by a British Heart Foundation Immediate Fellowship FS/18/24/33424. I thank S. Meilhac for insightful discussions as well as comments regarding this article and S. Srinivas for his support and guidance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human samples, and all animal experiments complied with the UK Animals (Scientific Procedures) Act 1986 were approved by the local Biological Services Ethical Review Process and were performed under UK Home Office project licenses PPL30/3420 and PCB8EF1B4.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tyser, R.C.V. Formation of the Heart: Defining Cardiomyocyte Progenitors at Single-Cell Resolution. Curr Cardiol Rep 25, 495–503 (2023). https://doi.org/10.1007/s11886-023-01880-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-023-01880-z